Jane Street’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.3M | Sell |
1,752,646
-289,023
| -14% | -$11.8M | 0.01% | 952 |
|
|
2026
Q1 | $67.8M | Buy |
2,041,669
+1,071,694
| +110% | +$31.9M | 0.01% | 863 |
|
|
2025
Q4 | $28.9M | Sell |
969,975
-158,785
| -14% | -$5.19M | ﹤0.01% | 1291 |
|
|
2025
Q3 | $40.8M | Buy |
1,128,760
+423,748
| +60% | +$14M | 0.01% | 1073 |
|
|
2025
Q2 | $25.4M | Buy |
705,012
+345,818
| +96% | +$12.9M | 0.01% | 1237 |
|
|
2025
Q1 | $14.2M | Buy |
359,194
+330,456
| +1,150% | +$11.1M | ﹤0.01% | 1598 |
|
|
2024
Q4 | $865K | Sell |
28,738
-48,639
| -63% | -$1.4M | ﹤0.01% | 5656 |
|
|
2024
Q3 | $1.81M | Sell |
77,377
-337,686
| -81% | -$7.38M | ﹤0.01% | 4688 |
|
|
2024
Q2 | $7.38M | Buy |
415,063
+190,801
| +85% | +$3.04M | ﹤0.01% | 2403 |
|
|
2024
Q1 | $3.41M | Sell |
224,262
-370,663
| -62% | -$5.9M | ﹤0.01% | 3199 |
|
|
2023
Q4 | $10.2M | Buy |
594,925
+150,722
| +34% | +$1.75M | ﹤0.01% | 1933 |
|
|
2023
Q3 | $3.71M | Sell |
444,203
-221,868
| -33% | -$3.09M | ﹤0.01% | 3043 |
|
|
2023
Q2 | $16.5M | Buy |
666,071
+473,909
| +247% | +$12.2M | 0.01% | 1402 |
|
|
2023
Q1 | $2.89M | Sell |
192,162
-500,690
| -72% | -$7.61M | ﹤0.01% | 3208 |
|
|
2022
Q4 | $8.2M | Buy |
692,852
+186,934
| +37% | +$1.36M | ﹤0.01% | 1840 |
|
|
2022
Q3 | $3M | Buy |
505,918
+47,758
| +10% | +$313K | ﹤0.01% | 3462 |
|
|
2022
Q2 | $1.95M | Buy |
458,160
+94,040
| +26% | +$587K | ﹤0.01% | 4218 |
|
|
2022
Q1 | $3.46M | Buy |
364,120
+184,321
| +103% | +$2.13M | ﹤0.01% | 3677 |
|
|
2021
Q4 | $3.42M | Sell |
179,799
-148,305
| -45% | -$3.85M | ﹤0.01% | 3477 |
|
|
2021
Q3 | $10.9M | Buy |
328,104
+12,384
| +4% | +$383K | ﹤0.01% | 1705 |
|
|
2021
Q2 | $12.2M | Buy |
315,720
+132,869
| +73% | +$5.22M | ﹤0.01% | 1496 |
|
|
2021
Q1 | $8.81M | Buy |
182,851
+98,850
| +118% | +$4.75M | ﹤0.01% | 1683 |
|
|
2020
Q4 | $4.37M | Sell |
84,001
-52,381
| -38% | -$1.77M | ﹤0.01% | 2303 |
|
|
2020
Q3 | $3.65M | Buy |
136,382
+66,681
| +96% | +$1.53M | ﹤0.01% | 2210 |
|
|
2020
Q2 | $1.36M | Buy |
69,701
+49,862
| +251% | +$803K | ﹤0.01% | 3626 |
|
|
2020
Q1 | $195K | Sell |
19,839
-5,183
| -21% | -$65.5K | ﹤0.01% | 4663 |
|
|
2019
Q4 | $278K | Sell |
25,022
-3,336
| -12% | -$25.4K | ﹤0.01% | 4365 |
|
|
2019
Q3 | $159K | Buy |
28,358
+13,153
| +87% | +$91.7K | ﹤0.01% | 4708 |
|
|
2019
Q2 | $131K | Buy |
+15,205
| New | +$115K | ﹤0.01% | 4800 |
|
|
2016
Q1 | – | Sell |
-15,084
| Closed | -$180K | – | 4631 |
|
|
2015
Q4 | $180K | Buy |
+15,084
| New | +$191K | ﹤0.01% | 3655 |
|
|
2014
Q4 | – | Sell |
-21,755
| Closed | -$232K | – | 3025 |
|
|
2014
Q3 | $232K | Sell |
21,755
-79,004
| -78% | -$733K | ﹤0.01% | 2092 |
|
|
2014
Q2 | $946K | Buy |
+100,759
| New | +$644K | 0.01% | 947 |
|
|
2013
Q3 | – | Sell |
-24,227
| Closed | -$155K | – | 3106 |
|
|
2013
Q2 | $155K | Buy |
+24,227
| New | +$155K | ﹤0.01% | 2338 |
|
Other funds holding TGTX
SCM
CAM
Jane Street's TGTX Position: Q2 2026 in Review
Jane Street reduced its TG Therapeutics (TGTX) stake by 14% in Q2 2026, selling an estimated $11.8M and leaving 1,752,646 shares worth $96.3M. The position accounts for 0.01% of the portfolio, ranked #952.
Jane Street first reported a position in TGTX in Q2 2013 and has held it in 33 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Jane Street held 1,752,646 shares of TG Therapeutics worth $96.3M as of Q2 2026.
- Jane Street sold 289,023 TG Therapeutics shares in Q2 2026, an estimated $11.8M.
- TG Therapeutics made up 0.01% of Jane Street's portfolio in Q2 2026, its #952 holding.
- Jane Street first reported a position in TG Therapeutics in Q2 2013 and has held it in 33 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.